Vistagen Therapeutics, Inc. (VTGN)

Vistagen Therapeutics Analyst Ratings

• Total Analysts: 3
• Consensus Rating: Hold
• Price Target: $0.90
• Upside: +53.43%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Tim Lugo William Blair	William Blair	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Dec 17, 2025
Jason McCarthy Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Dec 17, 2025
Andrew Tsai Jefferies	Jefferies	Strong Buy → Hold Downgrades $15 → $0.9	Strong Buy → Hold	Downgrades	$15 → $0.9	+53.43%	Dec 17, 2025
Andrew Tsai Jefferies	Jefferies	Hold → Strong Buy Upgrades $0.2 → $15	Hold → Strong Buy	Upgrades	$0.2 → $15	+2,457.11%	Dec 7, 2023
Paul Matteis Stifel	Stifel	Strong Buy Initiates $12	Strong Buy	Initiates	$12	+1,945.69%	Nov 14, 2023
Jason McCarthy Maxim Group	Maxim Group	Strong Buy Maintains $30	Strong Buy	Maintains	$30	+5,014.22%	Sep 5, 2023
Jason McCarthy Maxim Group	Maxim Group	Hold → Strong Buy Upgrades $30	Hold → Strong Buy	Upgrades	$30	+5,014.22%	Aug 7, 2023
Jason McCarthy Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jul 26, 2022
Tim Lugo William Blair	William Blair	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Jul 22, 2022
Brian Skorney Baird	Baird	Buy Initiates $270	Buy	Initiates	$270	+45,927.96%	May 20, 2021
Andrew Tsai Jefferies	Jefferies	Strong Buy Initiates $180	Strong Buy	Initiates	$180	+30,585.31%	Feb 18, 2021
Tim Lugo William Blair	William Blair	Hold → Buy Upgrades n/a	Hold → Buy	Upgrades	n/a	n/a	Jan 4, 2021
Nathan Weinstein Aegis Capital	Aegis Capital	Strong Buy Initiates $180	Strong Buy	Initiates	$180	+30,585.31%	Oct 8, 2020
Tim Lugo William Blair	William Blair	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Aug 28, 2019
Jason McCarthy Maxim Group	Maxim Group	Strong Buy Initiates $180	Strong Buy	Initiates	$180	+30,585.31%	Jun 27, 2018